Although the Bcl-2/Bax ratio in the stretch group was reduced to about 74% of the control-level in the in vitro stretch injury model, it did not reach statistical significance.
← all excerpts
Post-injury treatment with 7,8-dihydroxyflavone, a TrkB receptor agonist, protects against experimental traumatic brain injury via PI3K/Akt signaling.
1
—
—